AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Biomarker for Inflammatory Bowel Disease

Technology Application

The diagnosis of IBD using CEACAM6 as a biomarker to correlate to loss of PTPN2 activity.

Detailed Technology Description

None

Others

Background

Inflammatory Bowel Disease (IBD) includes Crohn’s Disease and ulcerative colitis (UC). There is no definitive test for diagnosing IBD and its diagnosis involves a number of invasive tests such as colonoscopies, biopsies and blood tests. Tests that screen for fecal inflammatory biomarkers and serological markers are in development. Given that IBD is a heterogeneous disease and subsets of patients may be defined by genetic and subclinical markers that reflect specific types of inflammation, each IBD subtype represents an opportunity for individualized treatment approaches. Therefore additional biomarkers that may be added to the panel of biomarkers to improve the diagnosis of IBD are essential.

Tech ID/UC Case

29390/2018-548-0

Related Cases

2018-548-0

Country/Region

USA

For more information, please click Here